GLSV co-finances Sandoz spin-off Nabriva GmbH(02 Feb 2006) Global Life Science Ventures (GLSV) announced the launch of Nabriva GmbH, a specialist antibiotic research and development company that has existed until now within Sandoz GmbH as the Vienna-based Antibiotic Research Institute (ABRI). GLSV is ...
Sandoz Files Lawsuit Seeking FDA Ruling on Omnitrope(16 Sep 2005) Sandoz announced that it has filed a lawsuit against the US Food and Drug Administration, seeking a ruling on its pending new drug application for the human growth hormone Omnitrope."We believe it is important for patients and health-care providers ...
Sandoz, Inc. to Drop Challenge to PROVIGIL(R) Patent(04 May 2005) Cephalon, Inc. reported that Sandoz, Inc. has notified Cephalon that it will no longer challenge Cephalon's U.S. particle-size modafinil patent. Instead, Sandoz said it intends to convert its abbreviated new drug application (ANDA) for approval of a ...
Top
